On Monday, Athira Pharma Inc (NASDAQ: ATHA) opened higher 6.17% from the last session, before settling in for the closing price of $6.97. Price fluctuations for ATHA have ranged from $2.20 to $8.36 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -72.27%. Company’s average yearly earnings per share was noted 75.23% at the time writing. With a float of $3.75 million, this company’s outstanding shares have now reached $3.94 million.
Athira Pharma Inc (ATHA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Athira Pharma Inc is 5.01%, while institutional ownership is 43.72%. The most recent insider transaction that took place on Jul 01 ’25, was worth 2,502. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 8,526 shares at a rate of $0.29, taking the stock ownership to the 168,901 shares. Before that another transaction happened on Jul 01 ’25, when Company’s President and CEO sold 25,123 for $0.29, making the entire transaction worth $7,374. This insider now owns 325,802 shares in total.
Athira Pharma Inc (ATHA) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -3.9 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -4.05) by 0.15.
According to the Wall Street analysts, stocks earnings will be around 75.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 74.87% during the next five years compared to -72.27% drop over the previous five years of trading.
Athira Pharma Inc (NASDAQ: ATHA) Trading Performance Indicators
Check out the current performance indicators for Athira Pharma Inc (ATHA). In the past quarter, the stock posted a quick ratio of 9.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.66, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -4.87 in one year’s time.
Technical Analysis of Athira Pharma Inc (ATHA)
Looking closely at Athira Pharma Inc (NASDAQ: ATHA), its last 5-days average volume was 12.51 million, which is a jump from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 70.83%.
During the past 100 days, Athira Pharma Inc’s (ATHA) raw stochastic average was set at 81.26%, which indicates a significant increase from 78.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.45 in the past 14 days, which was higher than the 0.30 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.33, while its 200-day Moving Average is $3.63. However, in the short run, Athira Pharma Inc’s stock first resistance to watch stands at $7.94. Second resistance stands at $8.47. The third major resistance level sits at $9.18. If the price goes on to break the first support level at $6.70, it is likely to go to the next support level at $5.99. Should the price break the second support level, the third support level stands at $5.46.
Athira Pharma Inc (NASDAQ: ATHA) Key Stats
There are currently 3,944K shares outstanding in the company with a market cap of 29.18 million. Presently, the company’s annual sales total 0 K according to its annual income of -96,940 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,610 K.
